Table 1.
Baseline characteristics on ICU admission.
Table 2.
Episode characteristics.
Table 3.
Biochemical markers in predicting treatment failure and 28-day mortality.
Table 4.
Multiple logistic analysis for biochemical markers in predicting treatment failure and 28-day mortality.
Fig 1.
(a) Receiver operating characteristic (ROC) curves for procalcitonin (PCTc) and C-reactive protein (CRPc) clearance predict treatment failure. (b) Receiver operating characteristic (ROC) curves for procalcitonin (PCTc) and C-reactive protein (CRPc) clearance predict 28-day mortality. The test for AUC difference between the two markers had a p-value > 0.2 for both treatment failure and 28-day mortality.
Fig 2.
(a) Kaplan-Meier 28-day survival analyses comparing groups 1 (PCTc ≥ 78%) and 2 (PCTc < 78%). Solid line, group 1; dotted line, group 2; p = 0.001 based on log-rank tests. (b) Kaplan-Meier 28-day survival analyses comparing groups 3 (CRPc ≥ 36%) and 4 (PCTc < 36%). Solid line, group 3; dotted line, group 4; p < 0.001 based on log-rank tests.